Real-time enrollment status for this systemic sclerosis clinical trial
Current Status
Active, Not Recruiting
Checked: October 16, 2026 at 7:53 PM UTC
| NCT Number | NCT06655155 |
| Recruiting Status | Active, Not Recruiting |
| Condition | Systemic Sclerosis |
| Phase | PHASE2 |
| Target Enrollment | 81 participants |
| Active Locations | 9 sites in the US |
| Sponsor | argenx |
| Last Updated on CT.gov | October 16, 2026 (19 hours ago) |
As of October 16, 2026: Clinical trial NCT06655155 is currently active_not_recruiting participants. This phase2 study for systemic sclerosis is not currently accepting new participants at 9 locations across the United States. The study is sponsored by argenx. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT06655155 is currently active_not_recruiting. The study may resume recruiting in the future.
This trial is recruiting at 9 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06655155 was last updated 19 hours ago (October 16, 2026). HelloStudys verifies this status automatically.